Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:abbreviation |
Hayao
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1991
|
| gptkbp:headquarters_location |
gptkb:Harbin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Harbin Pharmaceutical Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Zhang_Xuejun
Yang Yihong |
| gptkbp:listedOn |
gptkb:Fortune_China_500
|
| gptkbp:market |
gptkb:China
international |
| gptkbp:notableProduct |
gptkb:traditional_medicine
antibiotics vitamins |
| gptkbp:numberOfEmployees |
over 20,000
|
| gptkbp:parentCompany |
Harbin Pharmaceutical Group Holding Co., Ltd.
|
| gptkbp:stockExchange |
gptkb:Shanghai_Stock_Exchange
|
| gptkbp:stockSymbol |
600664
|
| gptkbp:subsidiary |
gptkb:GNC_Holdings
|
| gptkbp:website |
http://www.hayao.com.cn/
|
| gptkbp:bfsParent |
gptkb:哈药集团
|
| gptkbp:bfsLayer |
6
|